morgan stanley

morgan stanley maintained an equal-weight rating on Dr Reddy’s Labs, citing missed Q4FY26 estimates and a slight delay in Semaglutide ramp-up. Kotak Institutional Equities recommended buying Dixon Technologies, driven by strong consumer electronics performance. Citigroup reiterated its buy on Max Financial, highlighting margin improvements and sustained growth. Macquarie rated Berger Paints underperform, despite a constructive outlook.

India’s macro exposure to the Middle East continues to be transmitted primarily through energy and critical input prices, reflecting structurally high dependence on imported crude and natural gas.

A former JP Morgan employee, Chirayu Rana, has accused senior executive Lorna Hajdini of sexual assault. New reports reveal Rana allegedly discussed similar claims of rape, assault, and forced drug use by a former boss with an online legal chatbot nearly 10 months ago. These public conversations also touched upon separation agreements and potential legal action.

Jefferies raised Bharti Airtel's target price to Rs 2,350 on strong Q4FY26 performance, while JP Morgan upgraded Cipla to overweight citing improved earnings visibility and attractive valuations. morgan stanley maintained an underweight rating on Dixon Technologies due to revenue and EBITDA misses, and HDFC Securities upgraded Hyundai Motor India to add, noting management's renewed focus on domestic growth and exports.

Arundhati Bhattacharya, Naina Lal Kidwai, Chanda Kochhar, Shikha Sharma were all leading some of the country’s largest financial institutions. Today, a striking number of global capability centres run in India by American, European and British banks and financial services firms are led by women. These centres span everything from core banking technology and risk management to advanced analytics and operations, supporting some of the world’s largest financial institutions and increasingly shaping how they function globally

Anthropic employees refused to sell their shares at the $350 billion tender offer earlier this year, and now we know why. The Claude maker has agreed a fresh $30 billion funding round at a $900 billion valuation, the Financial Times reported, nearly tripling its worth in three months. With revenue at $30 billion and an IPO expected by October, staff are sitting on a payday.

The Edmonton Oilers are facing growing pressure after another early playoff exit, and Darnell Nurse’s future has become a major offseason storyline. With four years remaining on his $74 million contract, Nurse has emerged as a possible trade candidate as Edmonton looks to reshape its roster around Connor McDavid’s championship window. NHL insider David Pagnotta linked the San Jose Sharks as a potential destination, though Nurse’s no-movement clause and sizeable cap hit could complicate any deal.

Rupee hit a fresh record low of 96.07 against the US dollar on Friday, extending its losing streak over three straight sessions amid soaring crude oil prices and escalating tensions in West Asia. At the interbank foreign exchange market, the rupee opened at 95.86 against the US dollar and slipped further to 95.94, down 30 paise from its previous close.

Leading financial institutions offer mixed outlooks on Indian stocks. morgan stanley sees SBI facing NIM challenges, while Goldman Sachs is bullish on Titan's jewellery segment. CLSA notes Bank of Baroda's core performance is mixed despite loan growth. Nomura backs Swiggy, highlighting food delivery strength and quick commerce competition. HSBC anticipates Hyundai's market share recovery and new launches.

Nvidia executive Bryan Catanzaro states AI is currently more costly than human workers. Major tech firms like Meta and Microsoft are cutting jobs while investing heavily in AI. Research shows AI is not yet cost-effective for many tasks. Experts believe this is a temporary imbalance, with AI costs expected to fall significantly by 2030.

Despite the bullish undertone in equities, several risk factors continue to keep investors on edge. The rupee touched a fresh record low after breaching the 95.8 mark against the US dollar for the first time.

Analysts are bullish on Bajaj Finance, IIFL Finance, and Navin Fluorine, citing strong quarterly results and positive future outlooks. Federal Bank is seen as fairly valued, while Waaree Engineering's revenue beat expectations despite margin concerns. Investors are watching these key companies closely.

Global oil inventories are rapidly depleting due to the Iran war disrupting crude flows from the Persian Gulf, leading to concerns of price spikes and shortages. Asia faces immediate pressure, with some nations potentially experiencing shortages within a month as reserves hit multi-year lows. Strategic reserves are being deployed, but this further weakens the global safety buffer.

New-age insurer Acko, backed by General Atlantic and Accel, is gearing up for its IPO, aiming for an early 2027 launch. The company has appointed morgan stanley, ICICI Securities, and Kotak Securities as bankers. Acko targets a valuation of $2-2.5 billion, a significant increase from its previous $1.4 billion. This move comes as India's IPO market navigates global volatility.

Anthropic's powerful AI model, Claude Mythos, capable of finding software vulnerabilities, has prompted a global financial sector scramble. Banks, regulators, and central bankers are urgently assessing risks and accelerating cybersecurity investments. Project Glasswing offers controlled access for defensive security work, highlighting the evolving threat landscape.

Analysts are bullish on Adani Ports, Indus Tower, and Voda Idea, citing strong performance and growth prospects. Kotak Bank shows solid operating metrics, though RoE lags peers. Bharti Airtel's outlook remains positive despite potential tariff hike delays, with industry repair seen as intact.

Oracle faces a significant bank-debt challenge due to its massive data centre expansion for OpenAI, reportedly requiring $300 billion. Lenders struggle with exposure limits, impacting their ability to finance these projects. This comes as Oracle also plans substantial job cuts, highlighting financial pressures despite efforts to secure funding.

Sun Pharmaceutical Industries Ltd has agreed to acquire US-based Organon & Co for $11.75 billion in an all-cash deal. This significant outbound acquisition is expected to close in early 2027, strengthening Sun Pharma's global presence in women's health and biosimilars.

The Indian rupee is facing significant pressure, weakening against the US dollar due to soaring crude oil prices driven by Middle East geopolitical tensions and persistent foreign fund outflows. Despite India's robust economic growth, the currency's slide continues as the Reserve Bank of India intervenes to curb volatility rather than target a specific exchange rate.